Co-Authors
This is a "connection" page, showing publications co-authored by Sebastian Havervall and Axel Rosell.
Connection Strength
0.825
-
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19. J Intern Med. 2022 01; 291(1):72-80.
Score: 0.242
-
Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers. JAMA. 2021 05 18; 325(19):2015-2016.
Score: 0.236
-
Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report. Arterioscler Thromb Vasc Biol. 2021 02; 41(2):878-882.
Score: 0.229
-
Response by Mackman et al to Letter Regarding Article, "Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report". Arterioscler Thromb Vasc Biol. 2021 06; 41(6):e381-e382.
Score: 0.059
-
Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19. Arterioscler Thromb Vasc Biol. 2021 02; 41(2):988-994.
Score: 0.057